EUVIMEDEUVIMED entdecken
Open Access

The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma

Xudong Mao, Xianjiong Chen, Zhehao Xu, Lifeng Ding, Wenqin Luo, Yudong Lin, Ruyue Wang, Liqun Xia, Mingchao Wang, Gonghui Li

Aging · 2024

DOI: 10.18632/aging.205782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Xudong Mao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Adenosine, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineImmunotherapyHumansPrognosisUrinary Bladder NeoplasmsGene Expression Regulation, NeoplasticBiomarkers, TumorCarcinoma, Transitional Cell

Stichwörter der Autor:innen

Cox proportional hazard modelN6-methyladenosindatabase analysisimmune genesimmunotherapeutic responseprognosisrandom survival forest variable huntingurothelial carcinoma

Substanzen

AdenosineBiomarkers, TumorN-methyladenosine

Autor:innen und Institutionen

  • Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

Zitieren

APA

Mao, X., Chen, X., Xu, Z., Ding, L., Luo, W., Lin, Y., Wang, R., Xia, L., Wang, M., & Li, G. (2024). The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma. Aging. https://doi.org/10.18632/aging.205782

Vancouver

Mao X, Chen X, Xu Z, Ding L, Luo W, Lin Y, et al. The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma. Aging. 2024. doi:10.18632/aging.205782

BibTeX
@article{Mao2024,
  author = {Mao, Xudong and Chen, Xianjiong and Xu, Zhehao and Ding, Lifeng and Luo, Wenqin and Lin, Yudong and Wang, Ruyue and Xia, Liqun and Wang, Mingchao and Li, Gonghui},
  title = {The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205782}
}
Kostenlos starten →